Characteristics of HIV target CD4 T cells collected using different sampling methods from the genital tract of HIV seronegative women
Authors:
Open Access
- 1 June 2017
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 12 (6) , e0178193
Abstract
Understanding the immune profile of CD4 T cells, the primary targets for HIV, in the female genital tract (FGT) is critical for evaluating and developing effective biomedical HIV prevention strategies in women. However, longitudinal investigation of HIV susceptibility markers expressed by FGT CD4 T cells has been hindered by low cellular yield and risk of sampling-associated trauma. We investigated three minimally invasive FGT sampling methods to characterize and compare CD4 T cell yield and phenotype with the goal of establishing feasible sampling strategies for immune profiling of mucosal CD4 T cells. FGT samples were collected bimonthly from 12 healthy HIV negative women of reproductive age in the following order: 1) Cervicovaginal lavage (CVL), 2) two sequential endocervical flocked swabs (FS), and 3) two sequential endocervical cytobrushes (CB1, CB2). Cells were isolated and phentoyped via flow cytometry. CD4 T cell recovery was highest from each individual CB compared to either CVL or FS (p < 0.0001). The majority of CD4 T cells within the FGT, regardless of sampling method, expressed CCR5 relative to peripheral blood (p < 0.01). Within the CB, CCR5+ CD4 T cells expressed significantly higher levels of α4β7, CD69, and low levels of CD27 relative to CCR5- CD4 T cells (all p < 0.001). We also identified CD4 Treg lineage cells expressing CCR5 among CB samples. Using three different mucosal sampling methods collected longitudinally we demonstrate that CD4 T cells within the FGT express CCR5 and α4β7 and are highly activated, attributes which could act in concert to facilitate HIV acquisition. FS and CB sampling methods can allow for investigation of strategies to reduce HIV target cells in the FGT and could inform the design and interpretation microbicide and vaccine studies in women.Keywords
Funding Information
- National Institutes of Health (1K23AI114407)
- National Institutes of Health (U01-AI-103408)
This publication has 48 references indexed in Scilit:
- Searching for Lower Female Genital Tract Soluble and Cellular Biomarkers: Defining Levels and Predictors in a Cohort of Healthy Caucasian WomenPLOS ONE, 2012
- Foreskin T-cell subsets differ substantially from blood with respect to HIV co-receptor expression, inflammatory profile, and memory statusMucosal Immunology, 2012
- Menstrual Blood as a Potential Source of Endometrial Derived CD3+ T CellsPLOS ONE, 2011
- Advances in the prevention of heterosexual transmission of HIV/AIDS among women in the United StatesInfectious Disease Reports, 2011
- Comparison of polyclonal expansion methods to improve the recovery of cervical cytobrush-derived T cells from the female genital tract of HIV-infected womenJournal of Immunological Methods, 2010
- The integrin α 4 β 7 forms a complex with cell-surface CD4 and defines a T-cell subset that is highly susceptible to infection by HIV-1Proceedings of the National Academy of Sciences, 2009
- Mucosal immunology of the genital and gastrointestinal tracts and HIV-1 infectionJournal of Reproductive Immunology, 2009
- The Tail of Integrins, Talin, and KindlinsScience, 2009
- Regulatory T-Cell Markers, Indoleamine 2,3-Dioxygenase, and Virus Levels in Spleen and Gut during Progressive Simian Immunodeficiency Virus InfectionJournal of Virology, 2007
- Initial Events in Establishing Vaginal Entry and Infection by Human Immunodeficiency Virus Type-1Immunity, 2007